In obesity and associated diseases, such as diabetes and cardiovascular disease, high plasma and tissue activities of secreted phospholipase A2 (sPLA2) enzymes, especially group IIA (GIIA) sPLA2s, have been demonstrated [1,2]. This evidence concerns the gene PLA2G1B and obesity due to melanocortin 4 receptor deficiency.